Kahira Pharmaceuticals & Chemical Industries Co. (CPCI) Financials
Annual financial statement highlights for Kahira Pharmaceuticals & Chemical Industries Co. covering fiscal years 2005–2026. Figures are updated weekly.
| Fiscal year | Revenue | Net income | EPS | Free cash flow | Total assets | Total debt | Dividend per share |
|---|---|---|---|---|---|---|---|
| 2026ended Jun 2026 · 84 months | 2.52B | 552.54M | 37.00 | 377.39M | 2.26B | 215.83M | — |
| 2019ended Jun 2019 | 962.94M | 85.17M | 5.70 | 117.39M | 1.06B | 0 | 2.00 |
| 2018ended Jun 2018 | 862.95M | 108.45M | 7.26 | 1.69M | 906.09M | 0 | 2.40 |
| 2017ended Jun 2017 | 690.18M | 97.92M | 6.56 | 112.14M | 861.32M | 0 | 2.00 |
| 2016ended Jun 2016 | 516.6M | 51.35M | 3.44 | 42.86M | 540.3M | 0 | 1.32 |
| 2015ended Jun 2015 | 450.98M | 43.36M | 2.90 | 20.41M | 551.88M | 0 | 1.01 |
| 2014ended Jun 2014 | 404.38M | 41.1M | 2.75 | -11.02M | 493.31M | 0 | 1.01 |
| 2013ended Jun 2013 | 374.81M | 53.98M | 3.61 | -10.97M | 451.94M | 0 | 1.60 |
| 2012ended Jun 2012 | 342.65M | 36.95M | 2.47 | -23M | 423.46M | 0 | 1.36 |
| 2011ended Jun 2011 | 305.58M | 45.01M | 3.01 | 36.39M | 407.95M | 0 | 1.60 |
| 2010ended Jun 2010 | 288.79M | 48.61M | 3.25 | 44.98M | 370.5M | 0 | 0.00 |
| 2009ended Jun 2009 | 268.61M | 51.71M | 3.46 | 38.67M | 418.38M | 0 | 2.19 |
| 2008ended Jun 2008 | 259.95M | 51.01M | 3.42 | 15.34M | 432.79M | 120,000 | 0.36 |
| 2007ended Jun 2007 | 244.13M | 45.84M | 3.07 | 46.09M | 423.24M | 460,000 | 1.94 |
| 2006ended Jun 2006 | 232.06M | 38.42M | 2.57 | 46.1M | 381.92M | 4.43M | 0.59 |
| 2005ended Jun 2005 | 223.68M | 30.18M | 2.02 | 40.09M | 394.14M | 26.24M | 1.51 |
All figures in EGP, as reported in the company’s annual results; updated weekly.